NCT00876824View on ClinicalTrials.gov

To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Leishmaniasis, Visceral
Interventions
DRUG

Amphotericin B Lipid emulsion

Amphotericin B lipid emulsion (Amphomul) 15 mg/kg on day 1 in group A for treatment of Visceral Leishmaniasis

DRUG

Liposomal Amphotericin B

Liposomal Amphotericin B in visceral leishmaniasis - 15 mg/kg on day 1 in group B

Trial Locations (4)

800001

Patna

800007

Patna

842001

Muzaffarpur

842003

Muzaffarpur

Sponsors
All Listed Sponsors
collaborator

Ministry of Science and Technology

AMBIG

lead

Bharat Serums and Vaccines Limited

INDUSTRY